Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1

Tomonobu Hasegawa, Maki Fukami, Naoko Sato, Noriyuki Katsumata, Goro Sasaki, Keiko Fukutani, Ken Ichirou Morohashi, Tsutomu Ogata

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Steroidogenic factor-1 (SF-1) regulates multiple genes involved in the adrenal and gonadal development and in the biosynthesis of a variety of hormones, including adrenal and gonadal steroids, anti-Mullerian hormone (AMH), and gonadotropins. We identified a novel SF-1 mutation in a 27-yr-old Japanese patient with a 46,XY karyotype. Sequence analysis was performed for all the seven exons of SF-1, revealing a heterozygous single base pair deletion at exon 2 (18delC) that is predicted to cause a frameshift at the sixth codon and resultant termination at the 74th codon. Functional studies showed that the mutation produced no demonstrable protein and had no transcription activity or dominant negative effect. Clinical features included small dysgenetic testes with vasa deferentia and epididymides, absent uterus, blind-ending vagina, clitoromegaly, and psychosexual disturbance. Endocrine studies showed normal adrenal function (cortisol response to ACTH stimulation, 13.4→25.3 μg/dl) and primary hypogonadism (testosterone response to hCG stimulation, 0.57→0.76 ng/ml; gonadotropin responses to GnRH stimulation: LH, 10→59 mIU/ml; FSH, 36→69 mlU/ml), and urinary steroid hormone profile analysis indicated grossly normal steroidogenic enzyme activities. The results suggest that SF-1 haploinsufficiency can selectively impair testicular development and permit the biosynthesis of AMH and testosterone in dysgenetic testes and the production of gonadotropins in pituitary gonadotropes.

Original languageEnglish
Pages (from-to)5930-5935
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number12
DOIs
Publication statusPublished - 2004 Dec

Fingerprint

Steroidogenic Factor 1
Adrenal Insufficiency
Gonadotropins
Anti-Mullerian Hormone
Mutation
Biosynthesis
Testosterone
Testis
Exons
Steroid hormones
Steroids
Hormones
Pituitary Gonadotropins
Haploinsufficiency
Hypogonadism
Terminator Codon
Epididymis
Enzyme activity
Vagina
Transcription

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. / Hasegawa, Tomonobu; Fukami, Maki; Sato, Naoko; Katsumata, Noriyuki; Sasaki, Goro; Fukutani, Keiko; Morohashi, Ken Ichirou; Ogata, Tsutomu.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 12, 12.2004, p. 5930-5935.

Research output: Contribution to journalArticle

Hasegawa, Tomonobu ; Fukami, Maki ; Sato, Naoko ; Katsumata, Noriyuki ; Sasaki, Goro ; Fukutani, Keiko ; Morohashi, Ken Ichirou ; Ogata, Tsutomu. / Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. In: Journal of Clinical Endocrinology and Metabolism. 2004 ; Vol. 89, No. 12. pp. 5930-5935.
@article{3ef92e727a9b45b8b16f7a49d79aa650,
title = "Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1",
abstract = "Steroidogenic factor-1 (SF-1) regulates multiple genes involved in the adrenal and gonadal development and in the biosynthesis of a variety of hormones, including adrenal and gonadal steroids, anti-Mullerian hormone (AMH), and gonadotropins. We identified a novel SF-1 mutation in a 27-yr-old Japanese patient with a 46,XY karyotype. Sequence analysis was performed for all the seven exons of SF-1, revealing a heterozygous single base pair deletion at exon 2 (18delC) that is predicted to cause a frameshift at the sixth codon and resultant termination at the 74th codon. Functional studies showed that the mutation produced no demonstrable protein and had no transcription activity or dominant negative effect. Clinical features included small dysgenetic testes with vasa deferentia and epididymides, absent uterus, blind-ending vagina, clitoromegaly, and psychosexual disturbance. Endocrine studies showed normal adrenal function (cortisol response to ACTH stimulation, 13.4→25.3 μg/dl) and primary hypogonadism (testosterone response to hCG stimulation, 0.57→0.76 ng/ml; gonadotropin responses to GnRH stimulation: LH, 10→59 mIU/ml; FSH, 36→69 mlU/ml), and urinary steroid hormone profile analysis indicated grossly normal steroidogenic enzyme activities. The results suggest that SF-1 haploinsufficiency can selectively impair testicular development and permit the biosynthesis of AMH and testosterone in dysgenetic testes and the production of gonadotropins in pituitary gonadotropes.",
author = "Tomonobu Hasegawa and Maki Fukami and Naoko Sato and Noriyuki Katsumata and Goro Sasaki and Keiko Fukutani and Morohashi, {Ken Ichirou} and Tsutomu Ogata",
year = "2004",
month = "12",
doi = "10.1210/jc.2004-0935",
language = "English",
volume = "89",
pages = "5930--5935",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1

AU - Hasegawa, Tomonobu

AU - Fukami, Maki

AU - Sato, Naoko

AU - Katsumata, Noriyuki

AU - Sasaki, Goro

AU - Fukutani, Keiko

AU - Morohashi, Ken Ichirou

AU - Ogata, Tsutomu

PY - 2004/12

Y1 - 2004/12

N2 - Steroidogenic factor-1 (SF-1) regulates multiple genes involved in the adrenal and gonadal development and in the biosynthesis of a variety of hormones, including adrenal and gonadal steroids, anti-Mullerian hormone (AMH), and gonadotropins. We identified a novel SF-1 mutation in a 27-yr-old Japanese patient with a 46,XY karyotype. Sequence analysis was performed for all the seven exons of SF-1, revealing a heterozygous single base pair deletion at exon 2 (18delC) that is predicted to cause a frameshift at the sixth codon and resultant termination at the 74th codon. Functional studies showed that the mutation produced no demonstrable protein and had no transcription activity or dominant negative effect. Clinical features included small dysgenetic testes with vasa deferentia and epididymides, absent uterus, blind-ending vagina, clitoromegaly, and psychosexual disturbance. Endocrine studies showed normal adrenal function (cortisol response to ACTH stimulation, 13.4→25.3 μg/dl) and primary hypogonadism (testosterone response to hCG stimulation, 0.57→0.76 ng/ml; gonadotropin responses to GnRH stimulation: LH, 10→59 mIU/ml; FSH, 36→69 mlU/ml), and urinary steroid hormone profile analysis indicated grossly normal steroidogenic enzyme activities. The results suggest that SF-1 haploinsufficiency can selectively impair testicular development and permit the biosynthesis of AMH and testosterone in dysgenetic testes and the production of gonadotropins in pituitary gonadotropes.

AB - Steroidogenic factor-1 (SF-1) regulates multiple genes involved in the adrenal and gonadal development and in the biosynthesis of a variety of hormones, including adrenal and gonadal steroids, anti-Mullerian hormone (AMH), and gonadotropins. We identified a novel SF-1 mutation in a 27-yr-old Japanese patient with a 46,XY karyotype. Sequence analysis was performed for all the seven exons of SF-1, revealing a heterozygous single base pair deletion at exon 2 (18delC) that is predicted to cause a frameshift at the sixth codon and resultant termination at the 74th codon. Functional studies showed that the mutation produced no demonstrable protein and had no transcription activity or dominant negative effect. Clinical features included small dysgenetic testes with vasa deferentia and epididymides, absent uterus, blind-ending vagina, clitoromegaly, and psychosexual disturbance. Endocrine studies showed normal adrenal function (cortisol response to ACTH stimulation, 13.4→25.3 μg/dl) and primary hypogonadism (testosterone response to hCG stimulation, 0.57→0.76 ng/ml; gonadotropin responses to GnRH stimulation: LH, 10→59 mIU/ml; FSH, 36→69 mlU/ml), and urinary steroid hormone profile analysis indicated grossly normal steroidogenic enzyme activities. The results suggest that SF-1 haploinsufficiency can selectively impair testicular development and permit the biosynthesis of AMH and testosterone in dysgenetic testes and the production of gonadotropins in pituitary gonadotropes.

UR - http://www.scopus.com/inward/record.url?scp=10344264981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10344264981&partnerID=8YFLogxK

U2 - 10.1210/jc.2004-0935

DO - 10.1210/jc.2004-0935

M3 - Article

VL - 89

SP - 5930

EP - 5935

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -